Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
An-Shen prescription is a Traditional Chinese Medicine (TCM) formula developed by the Hubei Provincial Hospital of Traditional Chinese Medicine for the treatment of adult chronic insomnia. The name "An-Shen" (安神) translates to "calming the spirit" or "tranquilizing the mind," which describes its primary therapeutic action in TCM theory. The prescription is typically a multi-herb combination administered orally, designed to address the underlying patterns of disharmony that lead to sleep disturbances. It has been evaluated in a multicenter, randomized, double-blind, placebo-controlled clinical trial (ChiCTR1900027594) to determine its efficacy in improving sleep quality and its safety profile in patients with chronic insomnia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on An-Shen prescription.